Related Experiment Video

Updated: Jun 4, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

[Expression of EPOR on acute leukemia cells and its clinical significance]

Guo-Li Cheng1, Wei Wang, Hong-Yi Wang

  • 1Department of Hematology, Qingdao Medical College Affiliated Hospital, Qingdao, Shandong Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|March 3, 2011
PubMed

Insights

Erythropoietin receptor (EPOR) is expressed on acute leukemia cells, but at lower rates and levels than in healthy controls. Expression levels differ between acute myelogenous leukemia and acute lymphoblastic leukemia subtypes.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Context:

  • Acute leukemia (AL) is a heterogeneous group of hematologic malignancies.
  • The role of erythropoietin receptor (EPOR) in leukemia pathogenesis is an area of ongoing research.
  • Understanding EPOR expression provides insights into leukemia cell biology.

Purpose:

  • To investigate the expression of EPOR on acute leukemia cells.
  • To determine the clinical significance of EPOR expression in AL.
  • To compare EPOR expression between different subtypes of acute leukemia.

Summary:

  • EPOR mRNA was detected in 57.5% of acute leukemia samples, with a mean expression level of 0.3549 ± 0.2800.
  • EPOR expression rates and levels were significantly lower in AL patients compared to the control group (p < 0.05).
  • No significant difference in EPOR expression rate was observed between acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL) (p > 0.05), but AML showed higher expression levels than ALL (p < 0.05).

Impact:

  • This study confirms EPOR expression on acute leukemia cells.
  • Findings suggest EPOR may play a role in leukemia, with differential expression between AML and ALL.
  • Results contribute to understanding the molecular landscape of acute leukemias and potential therapeutic targets.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...